Table 2 Anti-HPV 16, 18 or 6/11/16/18 serological responses, stratified by cytological and histological diagnoses (n = 4211)
From: Seroprevalence of Human Papillomavirus Types 6, 11, 16 and 18 in Chinese Women
| Â | Â | Anti-HPV 6/11/16/18 | Anti-HPV 16 | Anti-HPV 18 | Anti-HPV 6 | Anti-HPV 11 | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Histology | n | % | ORa(95% CI) | % | ORa(95% CI) | % | ORa(95% CI) | % | ORa(95% CI) | % | ORa(95% CI) |
Normal | 4028 | 14.7 | 1.0 | 5.4 | 1.0 | 2.1 | 1.0 | 7.7 | 1.0 | 3.0 | 1.0 |
CIN1 | 114 | 28.1 | 1.2 (0.7-1.9) | 14.0 | 1.3 (0.7-2.4) | 0.9 | 0.2 (0.03-1.9) | 12.3 | 0.9 (0.5-1.7) | 7.0 | 1.8 (0.8-4.0) |
CIN2 | 27 | 74.1 | 7.8 (3.2-19.1) | 44.4 | 6.2 (2.7-14.1) | 11.1 | 3.1 (0.8-11.3) | 29.6 | 2.5 (1.0-6.0) | 11.1 | 2.4 (0.7-8.8) |
≥CIN3 | 42 | 52.4 | 2.7 (1.4-5.2) | 47.6 | 6.7 (3.4-13.2) | 0.0 | n/a | 4.8 | 0.3 (0.1-1.2) | 4.8 | 0.9 (0.2-3.8) |